Health
A vaxxing problem: why aren’t more Australian companies producing vaccines? – Sydney Morning Herald
As global demand for vaccines remains massive, Australia’s currently idle manufacturing facilities could be repurposed in the fight against COVID-19.
Normal text sizeLarger text sizeVery large text size
In Melbourne, a manufacturing facility that could potentially be repurposed to help produce a COVID-19 vaccine sits idle. The facility owned by pharmaceutical company IDT Australia was opened in 2008 by then-premier John Brumby, and among the types of products made on its production line were antibiotics. But the facility fell into disuse as it became cheaper to manufacture medicines offshore.
In March, the federal Health Department asked IDT…
-
Business21 hours agoWhy is Alphabet stock worth less than Nvidia, Microsoft, Apple, and Amazon even though it is the most profitable S&P 500 company?
-
Noosa News21 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
General15 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
Noosa News18 hours agoTips to improve engagement – Proctor